Form 4: ANI Pharma Exec Sells Shares for Tax Purposes

Meredith Cook, SR. VP, General Counsel & Secretary of ANI Pharmaceuticals, disposed of 3,011 shares of common stock for tax withholding related to vested performance units.

Summary

• Meredith Cook, SR. VP, General Counsel & Secretary of ANI Pharmaceuticals, Inc., reported a disposition of common stock.
• The transaction involved 3,011 shares of Common Stock.
• The shares were disposed of on February 11, 2026, at a price of $76.25 per share.
• This disposition was for tax withholding purposes, exempt under Rule 16(b)-3.
• The shares were withheld in connection with the vesting of 8,104 performance stock units, which were granted on April 6, 2023.
• Following this transaction, Meredith Cook beneficially owns 71,363 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine administrative transaction related to executive compensation rather than a discretionary sale or a reflection of company performance.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider transactions, such as tax-related withholdings upon vesting of equity awards, are common across the pharmaceutical industry and generally do not signal significant operational or strategic shifts for the company.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine tax-related transaction by an executive, not indicative of a change in company fundamentals or strategy.
• Impacts the executive by fulfilling tax obligations related to vested equity awards.

Key Dates

Keywords

ANI Pharmaceuticals, ANIP, Meredith Cook, Insider Trading, Form 4, Stock Sale, Tax Withholding, Performance Stock Units, Executive Compensation